Clinical trial
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults With End-Stage Kidney Disease on Hemodialysis
NCT04646226 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults With End-Stage Kidney Disease on Hemodialysis
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 18, 2022
- Completion date
- August 31, 2027
- Enrollment
- 103 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage kidney disease, hemodialysis complication